NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
April 14, 2026 — Soligenix uses synthetic hypericin platform for multiple dermatologic treatments, streamlining drug development. Learn about its CTCL therapy, vaccine programs, and platform science advantages in biopharma innovation.
April 14, 2026 — New preclinical study reveals promising glioblastoma treatment breakthrough after decades of stagnation. Learn about potential tumor elimination and advancing research in deadly brain cancer treatment.
April 14, 2026 — GeoVax Labs targets the constrained mpox/smallpox vaccine market with its GEO-MVA candidate, aiming to break the single-supplier monopoly and boost global health security.
April 14, 2026 — Aclarion wins Diamond Pinnacle Award for AI innovation in chronic low back pain diagnosis. Nociscan platform uses biomarkers & algorithms to identify painful discs with 97% surgical success rate when used with other tools.
April 14, 2026 — NeuroOne Medical Technologies announces a 1-for-6 reverse stock split to regain Nasdaq compliance, effective April 2026. Learn how this impacts shareholders and the company's neurology-focused innovations.
April 14, 2026 — Reztart launches in the US with clinically backed metabolic nutrition drinks designed to support blood sugar stability, reduce cravings, and promote sustained energy using patented NGC technology.
April 13, 2026 — LIXTE Biotechnology reports 40% disease control in ovarian cancer trial with LB-100 compound. Interim results show promising survival trends and acceptable safety profile in combination therapy.
April 13, 2026 — LIXTE Biotechnology reports 40% disease control rate in ovarian cancer trial with LB-100 and dostarlimab, showing promising survival trends and safety. Learn more about this clinical breakthrough.
April 13, 2026 — Stanford scientists create a noninvasive urine test to predict bladder cancer immunotherapy needs, transforming treatment for 60,000 annual U.S. cases with personalized care.
April 13, 2026 — MindBio Therapeutics unveils the first AI voice analytics system to detect drug & alcohol impairment at work in real time, targeting mining & safety-critical industries globally.
April 13, 2026 — Oragenics begins Phase IIa trial for ONP-002, a first-in-class intranasal treatment for concussion and mild traumatic brain injury, addressing a major unmet medical need with no FDA-approved drugs available.
April 13, 2026 — Catalyst Crew Technologies assigns AI healthcare patents to Venezuelan subsidiary, advancing CardioAI, PulmoAI, and NeuroAI technologies for emerging markets. Strategic IP move supports telehealth expansion.
April 13, 2026 — VectorCertain's SecureAgent platform achieves 100% detection of AI agent scope expansion, validated across 1,000 adversarial scenarios. Learn how this breakthrough addresses the T2 threat impacting 1 in 8 enterprise breaches.
April 10, 2026 — Lixte Biotechnology advances LB-100, a first-in-class cancer therapy enhancing chemotherapy, radiation & immunotherapy efficacy while reducing toxicity through strategic partnerships.
April 10, 2026 — HITN partners with University of Rochester to air Parkinson's documentary for Hispanic community on World Parkinson's Day, addressing health disparities with Spanish-language resources.
April 10, 2026 — New research reveals how cancers evade immune detection through RNA cleanup. Blocking this process could expose hidden tumors and revolutionize cancer immunotherapy treatments for better patient outcomes.
April 10, 2026 — LIXTE Biotechnology advances LB-100 cancer drug & acquires Liora Technologies, integrating pharma innovation with radiotherapy to redefine oncology treatment strategies for difficult cancers.
April 10, 2026 — Annovis Bio raises $10M in public offering, extending cash runway through 2027 to advance buntanetap for Alzheimer's and Parkinson's disease treatment during critical Phase 3 trial period.
April 9, 2026 — Sakowitz Smiles Orthodontics in Winter Garden combines self-ligating braces, indirect bonding, and pediatric expertise for efficient, comfortable orthodontic care. Learn how this approach benefits families in Orlando.
April 9, 2026 — Darwin AG will present at Invest Stuttgart and Equity Forum Frankfurt in spring 2026, showcasing precision health innovations and 2025 financial results to investors.